A PET Study Following a Single Oral Dose of ITI-333 in Healthy Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is an open-label, single-dose study of up to 4 dose levels of ITI-333 in healthy male and female subjects. Each cohort will enroll 6 subjects. Subjects will have a baseline PET/CT scan and a postdose PET/CT scan using \[14C\]-MDL100907 to characterize 5-HT2A receptor occupancy
Epistemonikos ID: a749fec8f5daddeec3faf6ef88a5e08bcaf6fcf6
First added on: May 13, 2024